D-peptide inhibitors of the p53–MDM2 interaction for targeted molecular therapy of malignant neoplasms

The oncoproteins MDM2 and MDMX negatively regulate the activity and stability of the tumor suppressor protein p53, conferring tumor development and survival. Antagonists targeting the p53-binding domains of MDM2 and MDMX kill tumor cells both in vitro and in vivo by reactivating the p53 pathway, pro...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Liu, Min, Li, Chong, Pazgier, Marzena, Li, Changqing, Mao, Yubin, Lv, Yifan, Gu, Bing, Wei, Gang, Yuan, Weirong, Zhan, Changyou, Lu, Wei-Yue, Lu, Wuyuan
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2010
Teme:
Biological Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922601/
https://ncbi.nlm.nih.gov/pubmed/20660730
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1008930107
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items